Developmental pharmacokinetics of antibiotics used in neonatal ICU: focus on preterm infants
OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Neonatal Infections are among the most common reasons for admission to the intensive
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …
Epigenetic mechanisms contribute to intraindividual variations of drug metabolism mediated by cytochrome P450 enzymes
Significant interindividual and intraindividual variations on cytochrome P450 (CYP)-
mediated drug metabolism exist in the general population globally. Genetic polymorphisms …
mediated drug metabolism exist in the general population globally. Genetic polymorphisms …
Physiologically based pharmacokinetics modeling in the neonatal population—current advances, challenges, and opportunities
Physiologically based pharmacokinetic (PBPK) modeling is an approach to predicting drug
pharmacokinetics, using knowledge of the human physiology involved and drug …
pharmacokinetics, using knowledge of the human physiology involved and drug …
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence
D Fu, HL Guo, YH Hu, WR Fang, QQ Liu, J Xu… - European Journal of …, 2023 - Springer
Purpose There is marked heterogeneity in treatment response of atomoxetine in patients
with attention deficit/hyperactivity disorder (ADHD), especially for the pediatric population …
with attention deficit/hyperactivity disorder (ADHD), especially for the pediatric population …
Practice of CYP450 genotyping and phenotyping in children in a real-life setting
Pharmacokinetics varies widely between children. Many factors play an important role in this
variability, such as ontogeny, pharmacogenetics, gender, comorbidities, and drug-drug …
variability, such as ontogeny, pharmacogenetics, gender, comorbidities, and drug-drug …
Successful Management of Fetal Torsades de Pointes and Long QT Syndrome by a Cardio-Obstetrical Team
M Putra, YM Lee, E Bucholz, EL Ross, H Galan… - Case Reports, 2023 - jacc.org
A 32-week fetus with tachycardia and bradycardia, diagnosed with torsades de pointes,
atrioventricular block, and sinus bradycardia due to a de novo KCNH2 mutation was …
atrioventricular block, and sinus bradycardia due to a de novo KCNH2 mutation was …
Case report: Use of therapeutic drug monitoring and pharmacogenetic testing as opportunities to individualize care in a case of flecainide toxicity after fetal …
R Palmen, T Sandritter, L Malloy-Walton… - Frontiers in …, 2023 - frontiersin.org
Flecainide is a class IC antiarrhythmic utilized in prophylaxis of refractory paroxysmal
supraventricular tachycardias in pediatric populations. Despite being a highly effective …
supraventricular tachycardias in pediatric populations. Despite being a highly effective …
[PDF][PDF] The Clinical Application of Pharmacogenetics in Understanding Drug Response
PS Kee - 2023 - ourarchive.otago.ac.nz
Pharmacogenetics focuses on heritable factors that influence drug responses. For a given
drug and patient, pharmacogenetics aims to optimise the intended therapeutic benefits …
drug and patient, pharmacogenetics aims to optimise the intended therapeutic benefits …